scholarly journals With regard to the implementation of the AGREE instrument in atrial fibrillation clinical guidelines

Medwave ◽  
2016 ◽  
Vol 16 (01) ◽  
pp. e6367-e6367
Author(s):  
Alberto Morales Salinas ◽  
Sergio Dubner ◽  
Daniel José Piñeiro
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Guidelines ◽  
Agree Instrument

scholarly journals Reply to the comment: With regard to the implementation of the AGREE instrument in Atrial Fibrillation Clinical Guidelines

Medwave ◽  
2016 ◽  
Vol 16 (01) ◽  
pp. e6381-e6381
Author(s):  
José Kelvin Galvez-Olortegui ◽  
Mayita Lizbeth Álvarez-Vargas ◽  
Tomas Vladimir Galvez-Olortegui ◽  
Armando Godoy-Palomino ◽  
Luis Camacho-Saavedra
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Guidelines ◽  
Agree Instrument

scholarly journals Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020

2022 ◽  
Vol 17 (6) ◽  
pp. 831-836
Author(s):  
A. S. Gerasimenko ◽  
O. V. Shatalova ◽  
V. S. Gorbatenko ◽  
V. I. Petrov
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Clinical Guidelines ◽  
Antithrombotic Therapy ◽  
Heart Valves ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
International Normalized Ratio ◽  
Prosthetic Heart Valves ◽  
Discharge From Hospital

Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) in real clinical practice, to evaluate changes of prescriptions from 2012 till 2020.Material and methods. The medical records of inpatients (Form 003/y) with the diagnosis AF, hospitalized in the cardiological department were analyzed. According to the inclusion criteria, the patients were over 18 years of age, established diagnosis of non-valvular AF. There were two exclusion criteria: congenital and acquired valvular heart disease and prosthetic heart valves. In retrospective analysis we have included 263 case histories in 2012, 502 ones in 2016 and 524 in 2020. CHA2DS2-VASc score was used for individual stroke risk assessment in AF. The rational use of the antithrombotic therapy was evaluated according with current clinical practice guidelines at analyzing moment.Results. During period of observation the frequency of antiplatelet therapy significantly decreased from 25,5% to 5,5% (р<0.001), decreased the frequency of administration of warfarin from 71,9% to 18,3% (р<0.001). The frequency of use of direct oral anticoagulants increased in 2020 compared to 2016 (р<0.001). For patients with a high risk of stroke anticoagulant therapy was administered in 71.8% of cases in 2012, 88.5% in 2016 and 92.5% in 2020. Before discharge from hospital majority of patients (72%) achieved a desired minimum international normalized ratio (INR) from 2.0 to 3.0 in 2012. In 2016 and 2020 an only 33% and 40.6% of patients achieved INR (2.0-3.0).Conclusion. Doctors have become more committed to following clinical guidelines during the period of the investigation. In 2020 antithrombotic therapy for atrial fibrillation was suitable according to current clinical guidelines.

A Critical Review of Low Back Pain Guidelines

2017 ◽  
Vol 65 (9) ◽  
pp. 388-394 ◽  
Author(s):  
Laran Chetty
Keyword(s):  
Health Care ◽  
Low Back Pain ◽  
Back Pain ◽  
Clinical Practice ◽  
Health Care Professionals ◽  
Critical Review ◽  
Clinical Guidelines ◽  
Research Evidence ◽  
Low Back ◽  
Agree Instrument

Low back pain (LBP) remains one of the most common and challenging musculoskeletal conditions encountered by health care professionals and is a leading cause of absenteeism. Clinical guidelines are often considered best evidence in health care. The aim of this critical review was to assess the quality and recommendations of LBP guidelines using the Appraisal of Guidelines Research and Evaluation (AGREE) instrument. Electronic databases were used to identify LBP guidelines published between 2000 and 2015. Nine guidelines were selected for review from a total of 17. Only five guidelines effectively addressed the AGREE scoring. On the basis of the appraisal and domain scores, only four guidelines were strongly recommended. Improved translation of research evidence from guidelines to clinical practice is needed.

scholarly journals Atrial fibrillation treatment in Russia: work on bugs

2021 ◽  
Vol 28 (3) ◽  
pp. 1-4
Author(s):  
S. G. Kanorskii
Keyword(s):  
Atrial Fibrillation ◽  
Clinical Practice ◽  
Russian Federation ◽  
Medical Errors ◽  
Clinical Guidelines ◽  
The Future ◽  
The Russian Federation ◽  
Real Clinical Practice

The article discusses the results of a survey of doctors in the Russian Federation with the aim of studying approaches to the treatment of atrial fibrillation in real clinical practice and comparing the results obtained with the current clinical guidelines. Some new data are presented that could change the recommendations in the future; possible causes of medical errors and ways to correct them are discussed.

scholarly journals New guidelines on cardiovascular diseases and the results of clinical research: Review of European Cardiology Congress 2018

2019 ◽  
Vol 23 (1) ◽  
pp. 27-34
Author(s):  
Elena V. Frolova
Keyword(s):  
Atrial Fibrillation ◽  
Health Care ◽  
Clinical Trials ◽  
Cardiovascular Diseases ◽  
Arterial Hypertension ◽  
Clinical Research ◽  
Clinical Guidelines ◽  
Digital Technologies ◽  
Research Review ◽  
New Guidelines

In this review the information is presented about new clinical guidelines on arterial hypertension, syncope guidelines, about screening of atrial fibrillation and antithrombotic and anticoagulants usage according clinical trials data. Attention is payed to digital technologies in health care sector. This information is based on data of European Cardiology Congress 2018.

Patient education

ESC CardioMed ◽  
2018 ◽  
pp. 2249-2252
Author(s):  
Deirdre A. Lane
Keyword(s):  
Atrial Fibrillation ◽  
Patient Education ◽  
Patient Preferences ◽  
Clinical Guidelines ◽  
Treatment Options ◽  
Informed Choice ◽  
Educational Interventions ◽  
Treatment Decisions ◽  
Nice Guidelines ◽  
To Receive

Contemporary international clinical guidelines recommend inclusion of patient preferences in treatment decisions regarding the management of atrial fibrillation (AF). Patient involvement in treatment decisions warrants at least a basic understanding of the condition and the treatment options available, yet the majority of patients with AF have little or no understanding of the nature and trajectory of the disease when they are first diagnosed, when treatment decisions invariably need to be taken. Making an informed choice about treatment requires the patient to receive education and information about AF, yet with the exception of the NICE guidelines on the management of AF, current clinical guidelines do not offer advice about what information a patient with AF needs (and wants) to know. This chapter offers guidance from consensus-based recommendations on the content of educational sessions for patients with AF, and provides examples of successful educational interventions and information on useful resources to help educate patients with AF about their condition and its treatment.

Sign in / Sign up

Export Citation Format

Share Document